menu
    • menu

    Company profile for Phosplatin Therapeutics

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Phosplatin therapeutics is a clinical stage pharmaceutical company founded by two entrepreneurs, based on over twenty years of work by the inventor. We are currently developing phosphaplatins, a family of rationally designed small-molecule agents for the treatment of cancer. The lead agent, pt-112, combines apoptotic and immunogenic properties in combating cancer, along with an exceptional tolerability profile. It was rationa...
    Phosplatin therapeutics is a clinical stage pharmaceutical company founded by two entrepreneurs, based on over twenty years of work by the inventor. We are currently developing phosphaplatins, a family of rationally designed small-molecule agents for the treatment of cancer. The lead agent, pt-112, combines apoptotic and immunogenic properties in combating cancer, along with an exceptional tolerability profile. It was rationally designed to avoid the toxicity and drug resistance mechanisms common to conventional chemotherapy. Because of its unique properties, pt-112 is being investigated in both solid tumors & hematological malignancies.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Phosplatin TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1350 AVENUE OF THE AMERICAS 23RD FL. NEW YORK, NY 10019-4703
    Telephone
    Telephone
    (646) 380-2441
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://phosplatin.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/phosplatin-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Promontory Therapeutics 'can't hire fast enough' amid expansion
    Promontory Therapeutics 'can't hire fast enough' amid expansion

    15 Jun 2022

    // Gabrielle Masson FIERCEBIOTECH

    https://www.fiercebiotech.com/biotech/delimiting-and-delivering-promontory-cofounder-cant-hire-fast-enough-small-biotech-expands

    Gabrielle Masson FIERCEBIOTECH
    15 Jun 2022
    Share Share
    Phosplatin Tx Adopts New Corporate Name as Promontory Therapeutics
    Phosplatin Tx Adopts New Corporate Name as Promontory Therapeutics

    05 May 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/phosplatin-therapeutics-adopts-new-corporate-name-as-promontory-therapeutics-inc-301540328.html

    PRNEWSWIRE
    05 May 2022
    Share Share
    Phosplatin doses first subject in Phase II thymic epithelial tumour trial
    Phosplatin doses first subject in Phase II thymic epithelial tumour trial

    14 Apr 2022

    // CLINICALTRIALSARENA

    https://www.clinicaltrialsarena.com/news/phosplatin-thymic-epithelial-tumour/

    CLINICALTRIALSARENA
    14 Apr 2022
    Share Share
    Phosplatin Tx Begins Dosing in Phase 2 Trial of PT-112
    Phosplatin Tx Begins Dosing in Phase 2 Trial of PT-112

    13 Apr 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/phosplatin-therapeutics-announces-first-patient-dosed-in-phase-2-clinical-trial-of-pt-112-for-thymoma-and-thymic-carcinoma-in-collaboration-with-national-cancer-institute-301524327.html

    PRNEWSWIRE
    13 Apr 2022
    Share Share
    Phosplatin Tx Appoints Lorenzo Galluzzi, PhD, to Scientific Advisory Board
    Phosplatin Tx Appoints Lorenzo Galluzzi, PhD, to Scientific Advisory Board

    24 Mar 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/phosplatin-therapeutics-appoints-lorenzo-galluzzi-phd-a-pioneer-in-immunogenic-cell-death-research-to-scientific-advisory-board-301509599.html

    PRNEWSWIRE
    24 Mar 2022
    Share Share
    Phosplatin Therapeutics Presents on PT-112 at the 2022 AACR
    Phosplatin Therapeutics Presents on PT-112 at the 2022 AACR

    10 Mar 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/phosplatin-therapeutics-presents-on-pt-112-at-the-2022-aacr-annual-meeting-selective-intracellular-effects-leading-to-immunogenic-cell-death-icd-in-prostate-cancer-cell-models-301499763.html

    PRNEWSWIRE
    10 Mar 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search